Notably, phenotype discordance in hormone receptors (ER and PR) and HER2 status between primary and recurrent breast cancer has been repeatedly reported [27, 28] and accounts, at least in part, to treatment failure [29]. This evidence concerns the gene ESR1 and breast cancer.